APA (7th ed.) Citation

Rajkhowa, B., Mehan, S., Sethi, P., Prajapati, A., Suri, M., Kumar, S., . . . Kalfin, R. (2025). RETRACTED: Rajkhowa et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals 2022, 15 , 959. Pharmaceuticals (14248247), 18(11), 1763. https://doi.org/10.3390/ph18111763

Chicago Style (17th ed.) Citation

Rajkhowa, Bidisha, et al. "RETRACTED: Rajkhowa Et Al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals 2022, 15 , 959." Pharmaceuticals (14248247) 18, no. 11 (2025): 1763. https://doi.org/10.3390/ph18111763.

MLA (9th ed.) Citation

Rajkhowa, Bidisha, et al. "RETRACTED: Rajkhowa Et Al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals 2022, 15 , 959." Pharmaceuticals (14248247), vol. 18, no. 11, 2025, p. 1763, https://doi.org/10.3390/ph18111763.